208P ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC
| dc.contributor.author | Schmid, P | en_US |
| dc.contributor.author | Gomez-Pardo, P | en_US |
| dc.contributor.author | Wheatley, D | en_US |
| dc.contributor.author | Roy, P | en_US |
| dc.contributor.author | Krabisch, P | en_US |
| dc.contributor.author | Thill, M | en_US |
| dc.contributor.author | Ledwidge, S | en_US |
| dc.contributor.author | Thompson, A | en_US |
| dc.contributor.author | Macaskill, EJ | en_US |
| dc.contributor.author | Viehstädt, N | en_US |
| dc.contributor.author | Purushotham, A | en_US |
| dc.contributor.author | Gluz, O | en_US |
| dc.contributor.author | Stefek, A | en_US |
| dc.contributor.author | Ackerman, C | en_US |
| dc.contributor.author | Prendergast, A | en_US |
| dc.contributor.author | Mousa, K | en_US |
| dc.contributor.author | Jones, L | en_US |
| dc.contributor.author | Viale, G | en_US |
| dc.contributor.author | Cortés, J | en_US |
| dc.contributor.author | Kümmel, S | en_US |
| dc.date.accessioned | 2022-06-14T08:49:47Z | |
| dc.date.issued | 2021-09 | en_US |
| dc.identifier.issn | 0923-7534 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/78899 | |
| dc.format.extent | s449 - s450 | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.ispartof | Annals of Oncology | en_US |
| dc.title | 208P ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC | en_US |
| dc.type | Article | |
| dc.identifier.doi | 10.1016/j.annonc.2021.08.490 | en_US |
| pubs.notes | Not known | en_US |
| pubs.volume | 32 | en_US |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
